Antiphospholipid antibodies and preeclampsia: a case-control study.

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Hematology

Background:

• Preeclampsia is a pregnancy complication characterized by hypertension and proteinuria.
• Antiphospholipid antibodies are associated with thrombotic events and pregnancy complications.
• The role of antiphospholipid antibodies in first-time preeclampsia is not fully understood.

Purpose of the Study:

• To investigate the association between antiphospholipid antibodies and the first occurrence of preeclampsia.
• To determine if lupus anticoagulant and anticardiolipin antibodies are risk factors for preeclampsia.

Main Methods:

• A prospective case-control study was conducted with 180 women experiencing their first preeclampsia and 360 matched controls.
• Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies) and coagulation markers were assessed.
• Preeclampsia was defined by specific blood pressure and proteinuria criteria.

Main Results:

• No significant association was found between antiphospholipid antibodies and preeclampsia (OR 0.95; 95% CI 0.45, 2.61).
• Antiphospholipid antibodies were detected in 4.4% of preeclamptic women and 5.3% of controls.
• A clear activation of coagulation was observed during preeclampsia.

Conclusions:

• Antiphospholipid antibodies are unlikely to be risk factors for first-time preeclampsia in women without prior thrombosis or autoimmune disease.
• Despite a prothrombotic state in preeclampsia, antiphospholipid antibodies do not appear to play a causative role.
• Further research is needed to elucidate the mechanisms of coagulation activation in preeclampsia.